Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-16

Natural antimony resistance in leishmania donovani: a fundamental study to guide future epidemiological strategies

Objective

Control of leishmaniasis is being challenged by the emergence of natural resistance against the first line treatment - pentavalent antimonials (SbV). Monitoring and prevention of the spreading of drug resistance is now a priority for the control of leishmaniasis.

In order to design and develop the required epidemiological tools, it is essential to understand the mechanism of natural SbV resistance and to gain insights into the dynamics of the emergence and/or spreading of drug resistance.

Within this context a multidisciplinary fundamental study is required to gain a comprehensive understanding of the natural SbV-resistance phenotype, including molecular basis, biochemical profile, and effect on parasite survival.

Fields of science (EuroSciVoc)

Keywords

Topic(s)

Call for proposal

FP6-2005-MOBILITY-5
See other projects for this call

Funding Scheme

EIF - Marie Curie actions-Intra-European Fellowships

Coordinator

UNIVERSITY OF GLASGOW
EU contribution
No data
Total cost
No data